Liver Metabolomics: Deciphering the Molecular Shift from Steatosis to Steatohepatitis
A comprehensive metabolomic analysis of liver tissue from patients with severe obesity has identified distinct biochemical signatures that differentiate simple steatosis from metabolic dysfunction-associated steatohepatitis (MASH). The study, published in Liver International, analyzed samples from 106 patients and validated findings in a second cohort of 227. Researchers discovered 45 metabolites with significant alterations, including novel associations for MASH such as elevated n-acetylneuraminate and decreased plasmalogens and UDP-galactose. Pathway analysis revealed that metabolites increased in MASH were linked to inflammatory processes, while those decreased were associated with disrupted fatty acid degradation and amino acid metabolism.
Why it might matter to you: This research provides a concrete molecular framework for understanding disease progression in MASLD, moving beyond histopathology alone. For a pathologist, these identified metabolites and pathways represent potential new diagnostic and prognostic biomarkers that could complement traditional tissue morphology assessment in biopsy analysis. The findings underscore the growing importance of integrating molecular diagnostics with conventional pathology to refine tumor grading, staging, and the identification of preneoplastic lesions in metabolic liver disease.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
